Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Adverse Cardiac Events Are Rare After Negative Cardiac CTA Test

By HospiMedica International staff writers
Posted on 20 Oct 2010
Adverse cardiac events are uncommon one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to new research.

Cardiac CTA is a noninvasive heart-imaging imaging modality that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle. More...
Earlier discharge of patients with low-to-moderate risk chest pain after negative initial testing and a cardiac CTA scan without significant coronary artery disease (CAD) may result in considerable savings in both cost and time in the emergency department, and may help alleviate emergency department congestion. With increasing awareness of such cost and time savings, emergency department practice is gradually leading toward the use of early cardiac CTA in some centers.

The study, performed at the University of Washington School of Medicine (Seattle, WA, USA), included 70 patients with negative cardiac CTA results who were interviewed in detail at 3, 6, and 12 months about intervening cardiac events, diagnostic testing and therapy.

"No patient reported any sign, symptom, finding, or subsequent diagnosis suggestive of an adverse cardiac event, nor was there any such suggestion in the electronic medical record,” said William P. Shuman, M.D., lead author of the study. "For earlier discharge based, in part, on negative cardiac CTA results to be clinically efficacious, it must be a safe practice with few subsequent adverse cardiac events. Our study shows that for patients with low-to-moderate risk chest pain evaluated in the emergency department, adverse cardiac events may be rare during the year after a negative cardiac CTA scan,” he concluded.

This study appears in the October 2010 issue of the American Journal of Roentgenology (AJR).

Related Links:

University of Washington School of Medicine



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.